Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$230,508,898
+$104,028,754 QoQ
Shares Held
1,215,636
+89.6% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#95
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $1,536,520,507 across 9 Drug Manufacturers - General names. AZN ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,162,034 | $549,091,774 | |
| 2 | LLY |
ELI LILLY & Co
|
396,979 | $476,148,561 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
1,215,636 | $230,508,898 | |
| 4 | ABBV |
AbbVie Inc.
|
775,386 | $195,118,133 | |
| 5 | MRK |
Merck & Co., Inc.
|
520,333 | $66,862,790 | |
| 6 | NVS |
Novartis AG
|
51,084 | $8,005,884 | |
| 7 | PFE |
Pfizer Inc
|
235,637 | $5,674,138 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,979 | $3,052,649 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $230,508,898 | 1,215,636 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $126,480,144 | 641,315 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||